Alchemi Data Management Awarded Patent for Ground-Breaking File-Based Protections
Granted earlier this month,
Dramatically lowering alert fatigue and costs associated with managing actual threats as well as false positives, Shield CRS employs a powerful combination of behavior analytics and artificial intelligence to help distinguish between normal behavior and malicious activity, ultimately isolating the source of any identified threat and enabling a rapid rollback and recovery of affected files. The result is a one-of-a-kind comprehensive insider threat platform that provides a high level of security and an assurance that strict compliance requirements are continually maintained.
"This patent underscores the uniqueness of ShieldCRS's approach to insider threat protection and the innovation behind our file-based security capabilities," said
Alchemi has applied for additional related patents. For more information on the ShieldCRS platform, visit www.shieldcrs.com.
About Alchemi Data Management
Alchemi Data Management Inc. provides holistic insider threat protection through its powerful ShieldCRS platform that identifies, isolates and remediates threats such as ransomware, IP theft and other digital sabotage. With attacks on a continual upswing and the related costs soaring, ShieldCRS was purpose-built to go after all forms of insider threats, harnessing its unique location within the network to go beyond security by also providing the data resilience and intelligence needed to achieve regulatory compliance. Founded in 2020, Alchemi Data Management is headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/alchemi-data-management-awarded-patent-for-ground-breaking-file-based-protections-302349325.html
SOURCE Alchemi Data Management
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CloudAvanti Achieves Approved Supplier Status with Canoe Procurement Group of Canada for Oracle Cloud ERP Implementation and Application Management Services
- Boost Global Patient Recruitment with Applied AI, Upcoming Webinar Hosted by Xtalks
- Insmed Announces Positive 12-Month Data from the Ongoing Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Patients with Pulmonary Arterial Hypertension
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share